Stephanie Morley

Stephanie Morley is a declared insider at 2 companies; the most frequent names are Zomedica Corp. and Zomedica Pharmaceuticals Corp. Between 29 March 2018 and 12 April 2021, the trades on record add up to 7 filings.

Every open-market trade on record is a sale: 2 sales worth €782k. Other entries cover 5 option exercises. Since January 2021: no purchases and 2 sales on the market.

Most recently, on 13 April 2021, the filings show an option exercise worth €49k in Zomedica Corp. The median gap between a trade and its publication by SEDI is 1 day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEDI disclosures alone and does not predict where the share price will go.